The system provides intravenous administration of propofol for minimal-to-moderate sedation during colonoscopy and EGD procedures. The system is also approved to allow physician-led teams administer propofol, rather than requiring an anesthesiologist to perform the sedation. However, the company will offer the system to “facilities where an anesthesia professional is immediately available for assistance or consultation,” according to the release.
The SEDASYS is designed to reduce over sedation and help healthcare facilities more effectively use limited resources.
More Articles on Anesthesia:
Masimo Rainbow Respiratory Monitor Cleared by FDA for Pediatric Use
Anesthesiologists Urge CMS, ONC to Continue Hardship Exemption Through MU Stage 3
11 Statistics on Anesthesiologists’ Compensation by Practice Setting
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
